February 23, 2023 11:49 AM EST
Manufacturing

Man­u­fac­tur­ing roundup: Eli Lil­ly’s Moun­jaro is mov­ing past a short­age — re­port; Mer­ck sells New Jer­sey fa­cil­i­ty  

Tyler Patchen

News Reporter

Eli Lil­ly’s di­a­betes drug Moun­jaro now seems to be avail­able once more.

Ac­cord­ing to a re­port from Bloomberg, the phar­ma gi­ant …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Will CRISPR mat­ter?

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times